Merck & Co. is putting down $30 million cash to buy Yale spinout Modifi Biosciences, a deal that includes a preclinical asset ...

Boston has become world-famous for its booming biotech industry. Over the past 20 years, the city has been buzzing with ...

Jefferies analyst Akash Tewari has assigned their bullish stance on ARVN stock, giving a Buy rating yesterday. Akash Tewari’s rating is ...

Chairman of the Senate Committee on Health, Education, Labor, and Pensions (HELP), today joined President Joe Biden in Concord, New Hampshire at the New Hampshire Technical Institute for an event on ...

I wasn't bothered when folks wanted to administer ivermectin to themselves or their loved ones when COVID was at its peak, ...

Individuals in Nigeria can greatly diminish their chances of experiencing diabetes and hypertension with thoughtful food ...

The drug generated $11.9bn in global sales in 2023 ... In the announcement accompanying the results, Elizabeth Rhee, vice ...

Alphina Therapeutics, a biotechnology company developing a best-in-class NAMPT inhibitor for the treatment of a range of ...

Beyond BNC210, Bionomics has a strategic partnership with Merck & Co., Inc. (known as MSD outside the United States and Canada) with two drugs in early-stage clinical trials for the treatment of ...

Moderna is focusing on respiratory vaccines to sustain revenue streams amid COVID-19 declines. See more on MRNA stock and its ...

Lori M. Reilly, chief operating officer at the Pharmaceutical Research and Manufacturers of America (PhRMA), a sponsor of the ...